Quality assurance in brachytherapy

Abstract

Quality assurance for high dose rate brachytherapy is governed not only by AAPM task group reports, but also by state and federal regulations. These regulations cover the periodic (treatment day) and quarterly (source exchange) tests that are required to ensure proper treatment. In addition, other task group reports review advances in brachytherapy treatments, such as improved dose calculations, as well as QA for imaging equipment including CT and ultrasound. Furthermore, a brachytherapy program audit can be conducted by the group to ensure the entire program is being properly managed.